X0306 4 2021-08-06 0 0001773751 Hims & Hers Health, Inc. HIMS 0001837796 Dudum Andrew 2269 CHESTNUT STREET, #523 SAN FRANCISCO CA 94123 1 1 1 0 Chief Executive Officer Class A Common Stock 2021-08-06 4 M 0 46238 11.50 A 8314803 I Held by Atomic Labs II, L.P. Class A Common Stock 2021-08-06 4 F 0 33893 D 8280910 I Held by Atomic Labs II, L.P. Class A Common Stock 186853 D Class A Common Stock 8232404 I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Class A Common Stock 2870509 I Held by Trustee of the AD GRAT dated 8/31/20 Warrant (right to buy) 11.50 2021-08-06 4 M 0 46238 0.00 D 2021-01-20 2026-01-20 Class A Common Stock 46238 0 I Held by Atomic Labs II, L.P. Atomic Labs II, L.P. exercised warrants to purchase shares of the Issuer's Class A Common Stock. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, Atomic Labs II, L.P. received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrants, the withholding of shares of Class A Common Stock in the cashless exercise and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Represents shares of Class A Common Stock withheld in connection with the cashless exercise. Mr. Dudum is a managing member of Atomic GP II, LLC, the general partner and manager of Atomic Labs II, L.P. Mr. Dudum may be deemed the beneficial owner of the shares held by Atomic Labs II, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. /s/ Soleil Boughton - Attorney-in-Fact 2021-08-06